Shares of Amrize Ltd (NYSE:AMRZ – Get Free Report) have received an average rating of “Moderate Buy” from the seventeen brokerages that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $64.8571.
Several analysts have recently issued reports on the stock. Truist Financial dropped their target price on shares of Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. Oppenheimer set a $68.00 price target on shares of Amrize in a research note on Friday, May 1st. Finally, Citigroup decreased their price target on shares of Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th.
Check Out Our Latest Research Report on AMRZ
Insider Buying and Selling at Amrize
Hedge Funds Weigh In On Amrize
Several hedge funds and other institutional investors have recently modified their holdings of AMRZ. Geode Capital Management LLC purchased a new position in shares of Amrize in the second quarter worth about $265,000. M&T Bank Corp purchased a new position in shares of Amrize in the second quarter worth about $205,000. Arrowstreet Capital Limited Partnership purchased a new position in shares of Amrize in the second quarter worth about $3,870,000. Gabelli Funds LLC purchased a new position in Amrize during the second quarter worth about $1,083,000. Finally, AXA S.A. purchased a new position in Amrize during the second quarter worth about $1,065,000.
Amrize Stock Up 1.6%
Shares of NYSE AMRZ opened at $53.19 on Friday. The company’s 50-day simple moving average is $54.07 and its 200-day simple moving average is $55.46. Amrize has a 52-week low of $44.12 and a 52-week high of $65.94. The firm has a market cap of $29.42 billion and a price-to-earnings ratio of 25.45. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38.
Amrize (NYSE:AMRZ – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion during the quarter. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. Equities analysts predict that Amrize will post 2.76 EPS for the current fiscal year.
Amrize Cuts Dividend
The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is currently 21.05%.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
- Five stocks we like better than Amrize
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
